Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Atorrasagasti, Catalina ^a   Peixoto, Estanislao ^a   Aquino, Jorge B ^a,b   Kippes, Néstor ^a   Malvicini, Mariana ^a   Alaniz, Laura ^a,b   Garcia, Mariana ^a,b   Piccioni, Flavia ^a   Fiore, Esteban J ^a   Bayo, Juan ^a   Bataller, Ramón ^c   Guruceaga, Elizabeth ^d   Corrales, Fernando ^d   Podhajcer, Osvaldo ^b,e   Mazzolini, Guillermo ^a,b  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NAVARRA   (Spain)

^e FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE A; MESSENGER RNA; OSTEONECTIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROGENESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

ANIMALS; BASE SEQUENCE; COLLAGEN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 84873659637     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054962     Document Type: Article

References (75)

1. Bradshaw AD, Sage EH, (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054.
2. Brekken RA, Sage EH, (2000) SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol 19: 569-580.
3. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, et al. (1999) SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. J Biol Chem 274: 32145-32152.
4. Wang JC, Lai S, Guo X, Zhang X, de Crombrugghe B, et al. (2010) Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther 12: R60.
5. Camino AM, Atorrasagasti C, Maccio D, Prada F, Salvatierra E, et al. (2008) Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J Gene Med 10: 993-1004.
6. Frizell E, Liu SL, Abraham A, Ozaki I, Eghbali M, et al. (1995) Expression of SPARC in normal and fibrotic livers. Hepatology 21: 847-854.
7. Blazejewski S, Le Bail B, Boussarie L, Blanc JF, Malaval L, et al. (1997) Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am J Pathol 151: 651-657.
8. Lamireau T, Le Bail B, Boussarie L, Fabre M, Vergnes P, et al. (1999) Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy. J Hepatol 31: 248-255.
9. Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, et al. (1999) Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol 189: 46-52.
10. Goldenberg D, Ayesh S, Schneider T, Pappo O, Jurim O, et al. (2002) Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays. Mol Carcinog 33: 113-124.
11. Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST, (2006) SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol 210: 459-468.
12. Gressner AM, Weiskirchen R, (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10: 76-99.
13. George J, Roulot D, Koteliansky VE, Bissell DM, (1999) In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A 96: 12719-12724.
14. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H, (1999) Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A 96: 2345-2349.
15. Wrana JL, Overall CM, Sodek J, (1991) Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur J Biochem 197: 519-528.
16. Muller A, Machnik F, Zimmermann T, Schubert H, (1988) Thioacetamide-induced cirrhosis-like liver lesions in rats-usefulness and reliability of this animal model. Exp Pathol 34: 229-236.
17. Oren R, Dotan I, Papa M, Marravi Y, Aeed H, et al. (1996) Inhibition of experimentally induced cirrhosis in rats by hypothyroidism. Hepatology 24: 419-423.
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435.
19. Jameson JM, Cauvi G, Sharp LL, Witherden DA, Havran WL, (2005) Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J Exp Med 201: 1269-1279.
20. Piccioni F, Malvicini M, Garcia MG, Rodriguez A, Atorrasagasti C, et al. (2012) Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology 22: 400-410.
21. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
22. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
23. Gentleman R (2005) Bioinformatics and computational biology solutions using R and Bioconductor: Springer Verlag.
24. Draghici S, Drǎghici S (2003) Data analysis tools for DNA microarrays: CRC Press.
25. George J, Tsutsumi M, Takase S, (2004) Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol 36: 307-319.
26. Kim DJ, Lee DC, Yang SJ, Lee JJ, Bae EM, et al. (2008) Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells. Biochem Biophys Res Commun 373: 521-527.
27. Grant AJ, Goddard S, Ahmed-Choudhury J, Reynolds G, Jackson DG, et al. (2002) Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 160: 1445-1455.
28. Marra F, (2002) Chemokines in liver inflammation and fibrosis. Front Biosci 7: d1899-1914.
29. Kanno M, Hasegawa M, Ishida A, Isono K, Taniguchi M, (1995) mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J 14: 5672-5678.
30. Tang X, Xing Z, Tang H, Liang L, Zhao M, (2011) Human cell-death-inducing DFF45-like effector C induces apoptosis via caspase-8. Acta Biochim Biophys Sin (Shanghai) 43: 779-786.
31. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S, (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
32. Moynahan ME, Chiu JW, Koller BH, Jasin M, (1999) Brca1 controls homology-directed DNA repair. Mol Cell 4: 511-518.
33. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, et al. (1998) Involvement of Brca2 in DNA repair. Mol Cell 1: 347-357.
34. Boulton SJ, Martin JS, Polanowska J, Hill DE, Gartner A, et al. (2004) BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans. Curr Biol 14: 33-39.
35. Zheng Z, Chen T, Li X, Haura E, Sharma A, et al. (2007) DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 356: 800-808.
36. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K, (2005) The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37: 953-957.
37. Ronen A, Glickman BW, (2001) Human DNA repair genes. Environ Mol Mutagen 37: 241-283.
38. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927-939.
39. Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, et al. (1999) The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 23: 266-268.
40. Wood RD, Mitchell M, Sgouros J, Lindahl T, (2001) Human DNA repair genes. Science 291: 1284-1289.
41. Bensimon A, Schmidt A, Ziv Y, Elkon R, Wang SY, et al. (2010) ATM-dependent and-independent dynamics of the nuclear phosphoproteome after DNA damage. Sci Signal 3: rs3.
42. Qin S, Parthun MR, (2002) Histone H3 and the histone acetyltransferase Hat1p contribute to DNA double-strand break repair. Mol Cell Biol 22: 8353-8365.
43. Bracken AP, Ciro M, Cocito A, Helin K, (2004) E2F target genes: unraveling the biology. Trends Biochem Sci 29: 409-417.
44. Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, et al. (2006) Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21: 437-457.
45. Meroni G, Diez-Roux G, (2005) TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27: 1147-1157.
46. Santamaria I, Velasco G, Pendas AM, Paz A, Lopez-Otin C, (1999) Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J Biol Chem 274: 13800-13809.
47. Socha MJ, Manhiani M, Said N, Imig JD, Motamed K, (2007) Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol 171: 1104-1112.
48. Strandjord TP, Madtes DK, Weiss DJ, Sage EH, (1999) Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis. Am J Physiol 277: L628-635.
49. Kisseleva T, Brenner DA, (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233: 109-122.
50. Atorrasagasti C, Aquino JB, Hofman L, Alaniz L, Malvicini M, et al. (2011) SPARC down-regulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-{beta}1 and PDGF. Am J Physiol Gastrointest Liver Physiol.
51. Bradshaw AD, Francki A, Motamed K, Howe C, Sage EH, (1999) Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol Biol Cell 10: 1569-1579.
52. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S, (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-807.
53. Rentz TJ, Poobalarahi F, Bornstein P, Sage EH, Bradshaw AD, (2007) SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J Biol Chem 282: 22062-22071.
54. Bradshaw AD, Baicu CF, Rentz TJ, Van Laer AO, Bonnema DD, et al. (2010) Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing. Am J Physiol Heart Circ Physiol 298: H614-622.
55. Benyon RC, Hovell CJ, Da Gaca M, Jones EH, Iredale JP, et al. (1999) Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 30: 977-986.
56. Radbill BD, Gupta R, Ramirez MC, DiFeo A, Martignetti JA, et al. (2011) Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression. Dig Dis Sci 56: 406-416.
57. Haimerl F, Erhardt A, Sass G, Tiegs G, (2009) Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-alpha-induced hepatocyte survival. J Biol Chem 284: 495-504.
58. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, et al. (2000) The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103: 757-768.
59. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, et al. (2002) Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416: 94-99.
60. Bromley SK, Thomas SY, Luster AD, (2005) Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6: 895-901.
61. Rempel SA, Hawley RC, Gutierrez JA, Mouzon E, Bobbitt KR, et al. (2007) Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response. Genes Immun 8: 262-274.
62. Sahin H, Trautwein C, Wasmuth HE, (2010) Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol 7: 682-690.
63. Atorrasagasti C, Aquino JB, Hofman L, Alaniz L, Malvicini M, et al. (2011) SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-beta1 and PDGF. Am J Physiol Gastrointest Liver Physiol 300: G739-748.
64. Yonezawa T, Kurata R, Kimura M, Inoko H, (2011) Which CIDE are you on? Apoptosis and energy metabolism. Mol Biosyst 7: 91-100.
65. Francki A, McClure TD, Brekken RA, Motamed K, Murri C, et al. (2004) SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells. J Cell Biochem 91: 915-925.
66. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, et al. (2011) Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43: 34-41.
67. Hanley KP, Oakley F, Sugden S, Wilson DI, Mann DA, et al. (2008) Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 283: 14063-14071.
68. Lim YS, Lee HC, Lee HS, (2007) Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells. Histochem Cell Biol 127: 149-160.
69. May P, May E, (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636.
70. Lu S, Shen KC, Wang Y, Brooks SC, Wang YA, (2005) Impaired hepatocyte survival and liver regeneration in Atm-deficient mice. Hum Mol Genet 14: 3019-3025.
71. Dubrovska A, Kanamoto T, Lomnytska M, Heldin CH, Volodko N, et al. (2005) TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage. Oncogene 24: 2289-2297.
72. Satterwhite DJ, Matsunami N, White RL, (2000) TGF-beta1 inhibits BRCA1 expression through a pathway that requires pRb. Biochem Biophys Res Commun 276: 686-692.
73. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D, (2003) Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38: 374-384.
74. Aleksunes LM, Scheffer GL, Jakowski AB, Pruimboom-Brees IM, Manautou JE, (2006) Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. Toxicol Sci 89: 370-379.
75. Aleksunes LM, Campion SN, Goedken MJ, Manautou JE, (2008) Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol Sci 104: 261-273.